T he beginning of human pharmacology involved the use of medicinal products isolated from plants, and occasionally, animals. Plants in particular were used because of their easy availability, many species, and ease of preparation, either as an infusion or preparations of the whole plant, both fresh and dry. In the 19th and 20th centuries human pharmacology was marked by the identification, isolation, and purification of specific molecular entities and, with the use of these entities (usually relatively small molecular weight compounds), identification of pharmacologic sites of action. The molecular structures of such sites are being identified. More recently in the past 2 decades large molecular weight substances, such as those originally derived from plants, have again made their appearance in pharmacology. Many of these have been synthesized in the laboratory by use of molecular biology techniques.
These compounds are not always proteins or small peptide chains but may also include complex carbohydrates and nucleotide sequences.
The paper by Mark et all in this issue describing the planned use of echinacea in the treatment of otitis media represents a 21st century attempt to quantitate the efficacy of one of these very old preparations. The use of herbs has received a great interest recently, and the passage of the Federal legislation in 1994 exempting dietary or food supplements from the same rigor of screening as drugs has led to widespread publicity of alleged nutritional and therapeutic attributes of these preparations. Much of the description of pharmacologic activity of herbal properties is anecdotal. Mark et all are to be commended in planning a study involving a standardized herbal product that will, it is hoped, have some consistency of preparation. We need to remember that the active components have not been, and will not be, identified in such a study. Such a study will also not identify mechanism of action. If herbs cure otitis, is it because they are bactericidal or because of some other property such as improving eustachian tube function? Can such studies be replicated? How will constancy of pharmaceutical preparations of this and other herbs be handled? Will there be a control group? Will an antibiotic be used in both groups with the intent that the group containing antibiotic/herb will have a better result than antibiotic/placebo? How large a study will be needed to show a difference? There are now 17 antibiotics available in the United States for the treatmen of otitis.2 Will herbal remedies offer any benefit? Studies comparing one with another will need to involve large numbers of subjects and even then differences in outcome may not be significant.
The use of herbal medications at present does not permit the identification and assay of any pharmacologic active moiety. Many plant preparations contain dozens, if not hundreds, of chemical moieties and it is very difficult to sort out active principles. Is nicotine the only active moiety in tobacco? How do we know that tetrahydrocannibal is the only active ingredient in marijuana?
There are many other concerns besides identification of active principles. The issue of stability with storage after harvesting is yet
to be satisfactorily answered for many herbs. If one cannot identify the active product, then one must utilize surrogate markers for purposes of quality control. What surrogate markers, if any, exist? For liquid preparations (infusions), the importance of the vehicle must be emphasized. Some liquids may extract active principles from a plant source while others may inactivate certain constituents. It is difficult to control for the presence of contaminants such as pesticides, heavy metals, or bacteria. The recent report in Pediatrics of lead poisoning in a child due to the chronic ingestion of a "Tibetan herbal product" from India containing large amounts of mercury and lead is illustrative.3 One common connection among some of the active principles that have been isolated from herbal products has been a complex organic chemical structure that may explain the mechanism of action of many plant-derived compounds such as birth control hormones, LSD (lysergic acid diethylamide), vincristine, digitalis, and quinine. Many plant preparations have dramatic, yet to be detailed, action in humans. Wade Davis, 4 in his book on the plants of the Amazon basin, dramatically describes extremely bizarre effects of crude plant preparations on the human brain. Because of the lack of quality control, even from batch to batch, herbal medications sold over the counter have undetermined purity, and the question may always be asked, "what is the proof of pharmaceutical quality?" For echinacea the authors propose using a preparation with an herb "strength" of 1:1. What does this mean? What constitutents are used for the 1:1 ratio? The United States Pharmacopeia has tried to establish monographs descriptive of the content and preparation for some of these preparations and they may prove useful for the practitioner to consult when asked ther-apeutic questions by patients. There are increasing reports of significant interactions between herbs and pharmaceutical drugs. 5 It is hoped that the approach taken by Mark et all by having a reliable pharmaceutically dependable product that can be applied to a clinical situation will help in identifying whether or not some of these preparations indeed have therapeutic properties.
